WES of mCRC xenografts under cetuximab treatment, placebo or after treatment release

Determine if cetuximab treatment selects any pre-existing resistant subclones or if the resistant cells, which in vivo determines residual disease, are driven by plasticity effects not linked to mutations.

Type: Other
Archiver: European Genome-Phenome Archive (EGA)

1 Dataset

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID	Description	Technology	Samples
EGAD00001005186	WES on cetuximab treated, untreated and release samples of two metastatic colorectal xenografts. First case: 3 cetuximab treated samples, 3 placebo and 3 release. Second case: 2 cetuximab treated samples, 2 placebo and 3 release. Paired fastq.	Illumina HiSeq 2500	16